Design and Synthesis of Benzimidazole Carboxamide Cysteine Protease Inhibitors as Promising Anti-leishmanial Agents
Authors:
- Gowsia AkhterGAGowsia Akhter
- Hinna HamidHHHinna Hamid
- Mirza A. BegMBMirza A. Beg
- Mushtaq A. TantrayMTMushtaq A. Tantray
- Bharti DhawanBDBharti Dhawan
- Mohammad Sarwar AlamMAMohammad Sarwar Alam
- Angamuthu SelvapandiyanASAngamuthu Selvapandiyan
- Sayeed Ur RehmanSRSayeed Ur Rehman
- Kalicharan SharmaKSKalicharan Sharma
- 1 September 2025
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 32 (31) , 6900-6928
Abstract
Introduction: More than 20 protozoan species of Leishmania are responsible for causing Leishmaniasis, an infection spread by blood-feeding phlebotomine sandflies. A narrow pool of drugs is currently available rendering the current drug stratagem to treat this infection . Development of novel, less toxic, and more effective regimens is thus a need of the hour. Design and synthesis of benzo[d]imidazole carboxamides as agents to combat Leishmaniasis are also required. Methods: 14 benzo[d]imidazole carboxamides were synthesized and gauged against L. donovani promastigotes and intramacrophage amastigote forms. All of the tested compounds exhibited significant anti-promastigote properties with IC50 well below 10 uM. Compounds 4a, 4b, and 4d, showing the highest anti-parasitic activity against promastigote forms (IC50 0.91- 1.33 μM), were also found to be associated with better anti-leishmanial potential (IC50 0.78- 1.67 μM) against the intramacrophage amastigotes comparable to Amphotericin-B (0.13 μM), a drug used for Leishmaniasis. Compound (4a), namely N-(2-(trifluoromethyl)-1Hbenzo[ d]imidazol-5-yl)benzo[d][1,3]-5-carboxamide-dioxole, was found to be most potent against L. donovani amastigotes among all the tested compounds, and demonstrated better antileishmanial properties (IC50 0.78 μM) when compared to the standard. Compound 4a was also assessed for its toxicity profile against THP-1 human monocytic cells. To establish the molecular target(s) in silico, molecular docking studies were performed against cysteine protease, a putative virulence factor of Leishmania parasites, and nucleoside diphosphate kinase, an enzyme with a critical role in nucleotide recycling, also associated with resistance in Leishmania strains. Compound 4a showed better binding affinity than the standard to these targets; furthermore, the molecular dynamic simulation studies further affirmed the stability of compound 4a, within the active site of the targets. In vitro, cysteine protease inhibitory activity (IC50 8.53 μM) using Bz-Arg-AMC hydrochloride fluorogenic peptide substrate established the promising potential of 4a as a cysteine protease inhibitor. Results: Computational ADMET analysis indicated appropriate pharmacokinetic profile and physicochemical characteristics for all members of the synthesized library. Conclusion: Both in vitro and in silico studies indicate that the synthesized imidazole carboxamides can act as potent hits and that N-(2-(trifluoromethyl)-1H-benzo[d]imidazol-5- yl)benzo[d][1,3]-5-carboxamide-dioxole 4a can be an effective hit molecule which can be further developed into potent lead molecule (s) to fight Leishmania donovani.Keywords
This publication has 67 references indexed in Scilit:
- 5‐Arylidene‐2,4‐thiazolidinediones as Cysteine Protease Inhibitors against Leishmania DonovaniChemistrySelect, 2023
- Anti-proliferative and apoptotic effects of green synthesized silver nanoparticles using Lavandula angustifolia on human glioblastoma cells3 Biotech, 2021
- Leishmaniasis: where are we and where are we heading?Parasitology Research, 2021
- A Review of Leishmaniasis: Current Knowledge and Future DirectionsCurrent Tropical Medicine Reports, 2021
- Recent advances and new strategies on leishmaniasis treatmentApplied Microbiology and Biotechnology, 2020
- Systematic search for benzimidazole compounds and derivatives with antileishmanial effectsMolecular Diversity, 2018
- Synthesis, protease inhibition, and antileishmanial activity of new benzoxazoles derived from acetophenone or benzophenone and synthetic precursorsMedicinal Chemistry Research, 2017
- A BOILED‐Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small MoleculesChemMedChem, 2016
- Benzimidazole derivatives: synthesis, leishmanicidal effectiveness, and molecular docking studiesMedicinal Chemistry Research, 2012
- GROMACS: Fast, flexible, and freeJournal of Computational Chemistry, 2005